Clinical practice: The bleeding child. Part I: primary hemostatic disorders
Mucocutaneous bleeding is common in childhood and may be the result of primary hemostatic disorders such as vascular abnormalities, von Willebrand disease, thrombocytopenia, and platelet dysfunction. A detailed bleeding history and physical examination are essential to distinguish between normal and...
Main Authors: | , |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer-Verlag
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249149/ |
id |
pubmed-3249149 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-32491492012-01-11 Clinical practice: The bleeding child. Part I: primary hemostatic disorders van Ommen, C. Heleen Peters, Marjolein Review Mucocutaneous bleeding is common in childhood and may be the result of primary hemostatic disorders such as vascular abnormalities, von Willebrand disease, thrombocytopenia, and platelet dysfunction. A detailed bleeding history and physical examination are essential to distinguish between normal and abnormal bleeding and to decide whether it is necessary to perform further laboratory evaluation. Initial laboratory tests include complete blood count, peripheral blood smear, mean platelet volume, von Willebrand factor (VWF) antigen assay, VWF ristocetin cofactor activity, and factor VIII activity. Once thrombocytopenia and von Willebrand disease have been excluded, platelet function should be tested by platelet aggregation. Additional specific diagnostic tests, such as platelet secretion tests and flow cytometry for the detection of platelet surface glycoprotein expression, are needed to confirm the raised hypothesis. Springer-Verlag 2011-07-29 2012-01 /pmc/articles/PMC3249149/ /pubmed/21800040 http://dx.doi.org/10.1007/s00431-011-1532-4 Text en © The Author(s) 2011 |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
van Ommen, C. Heleen Peters, Marjolein |
spellingShingle |
van Ommen, C. Heleen Peters, Marjolein Clinical practice: The bleeding child. Part I: primary hemostatic disorders |
author_facet |
van Ommen, C. Heleen Peters, Marjolein |
author_sort |
van Ommen, C. Heleen |
title |
Clinical practice: The bleeding child. Part I: primary hemostatic disorders |
title_short |
Clinical practice: The bleeding child. Part I: primary hemostatic disorders |
title_full |
Clinical practice: The bleeding child. Part I: primary hemostatic disorders |
title_fullStr |
Clinical practice: The bleeding child. Part I: primary hemostatic disorders |
title_full_unstemmed |
Clinical practice: The bleeding child. Part I: primary hemostatic disorders |
title_sort |
clinical practice: the bleeding child. part i: primary hemostatic disorders |
description |
Mucocutaneous bleeding is common in childhood and may be the result of primary hemostatic disorders such as vascular abnormalities, von Willebrand disease, thrombocytopenia, and platelet dysfunction. A detailed bleeding history and physical examination are essential to distinguish between normal and abnormal bleeding and to decide whether it is necessary to perform further laboratory evaluation. Initial laboratory tests include complete blood count, peripheral blood smear, mean platelet volume, von Willebrand factor (VWF) antigen assay, VWF ristocetin cofactor activity, and factor VIII activity. Once thrombocytopenia and von Willebrand disease have been excluded, platelet function should be tested by platelet aggregation. Additional specific diagnostic tests, such as platelet secretion tests and flow cytometry for the detection of platelet surface glycoprotein expression, are needed to confirm the raised hypothesis. |
publisher |
Springer-Verlag |
publishDate |
2011 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249149/ |
_version_ |
1611497514836426752 |